These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36631985)

  • 1. Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence.
    Tang J; Brynildsen MP
    Nucleic Acids Res; 2023 Feb; 51(3):1208-1228. PubMed ID: 36631985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
    Pantel A; Petrella S; Veziris N; Brossier F; Bastian S; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1990-6. PubMed ID: 22290942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.
    Caspar Y; Siebert C; Sutera V; Villers C; Aubry A; Mayer C; Maurin M; Renesto P
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase.
    Kumar R; Madhumathi BS; Nagaraja V
    Antimicrob Agents Chemother; 2014; 58(4):2013-20. PubMed ID: 24419347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluoroquinolone resistance associated mutation in gyrA Affects DNA supercoiling in Campylobacter jejuni.
    Han J; Wang Y; Sahin O; Shen Z; Guo B; Shen J; Zhang Q
    Front Cell Infect Microbiol; 2012; 2():21. PubMed ID: 22919613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
    Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
    Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
    PLoS Negl Trop Dis; 2012; 6(10):e1838. PubMed ID: 23071850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites.
    Lewis G; Juhasz A; Smith E
    Environ Sci Pollut Res Int; 2011 Aug; 19(7):2795-801. PubMed ID: 22311580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates.
    Ostrer L; Khodursky RF; Johnson JR; Hiasa H; Khodursky A
    Int J Antimicrob Agents; 2019 Mar; 53(3):318-324. PubMed ID: 30582984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
    Thapa J; Chizimu JY; Kitamura S; Akapelwa ML; Suwanthada P; Miura N; Toyting J; Nishimura T; Hasegawa N; Nishiuchi Y; Gordon SV; Nakajima C; Suzuki Y
    Microbiol Spectr; 2023 Jun; 11(3):e0508822. PubMed ID: 37067420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure.
    Sutera V; Hoarau G; Renesto P; Caspar Y; Maurin M
    Int J Antimicrob Agents; 2017 Sep; 50(3):377-383. PubMed ID: 28689870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
    Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
    J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ploidy is an important determinant of fluoroquinolone persister survival.
    Murawski AM; Brynildsen MP
    Curr Biol; 2021 May; 31(10):2039-2050.e7. PubMed ID: 33711253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
    Kern G; Palmer T; Ehmann DE; Shapiro AB; Andrews B; Basarab GS; Doig P; Fan J; Gao N; Mills SD; Mueller J; Sriram S; Thresher J; Walkup GK
    J Biol Chem; 2015 Aug; 290(34):20984-20994. PubMed ID: 26149691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impacts of DNA repair machinery on fluoroquinolone persisters with different chromosome abundances.
    Tang J; Herzfeld AM; Leon G; Brynildsen MP
    mBio; 2024 May; 15(5):e0037424. PubMed ID: 38564687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of antisense peptide-peptide nucleic acids against fluoroquinolone-resistant Escherichia coli.
    Kim SK; Lee JB; Lee HT; Han D; Yoon JW
    J Antimicrob Chemother; 2023 Aug; 78(8):2052-2060. PubMed ID: 37390375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
    Mayer C; Takiff H
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0009-2013. PubMed ID: 26104201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in
    Choudhary E; Sharma R; Kumar Y; Agarwal N
    Front Cell Infect Microbiol; 2019; 9():70. PubMed ID: 30972304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin Induction or Inhibition of Transcription or Translation Posttreatment Increases Persistence to Fluoroquinolones.
    Lemma AS; Brynildsen MP
    mBio; 2021 Aug; 12(4):e0198321. PubMed ID: 34399616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.